This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: **Etienne Moniotte: Innovator in Pharmaceutical Solutions**
Introduction
Etienne Moniotte, an esteemed inventor based in Vilvoorde, Belgium, has made notable contributions to the field of pharmaceuticals. With a keen focus on innovative methods for drug preparation, he holds a patent that highlights his expertise and forward-thinking approach in the medical science sector.
Latest Patents
Moniotte's most significant patent is titled "Solution phase method for preparing etelcalcetide." This innovative disclosure details solution phase fragment coupling methods aimed at producing etelcalcetide and its pharmaceutically acceptable salts. This patent exemplifies his commitment to advancing pharmaceutical methodologies and providing enhanced therapeutic options.
Career Highlights
Moniotte's career is marked by his role at Amgen Inc., a leading biotechnology company known for its research-driven approach to life-changing medicines. His contributions to the company have propelled advancements in drug formulation and synthesis.
Collaborations
Throughout his career, Etienne has collaborated with talented professionals in the industry, including notable coworkers such as Sheng Cui and Krishnakumar Ranganathan. These collaborations have undoubtedly enriched his work and fostered a dynamic environment for innovation at Amgen Inc.
Conclusion
In summary, Etienne Moniotte stands out as a significant figure in the realm of pharmaceutical innovations. His patent for etelcalcetide preparation showcases his dedication to improving healthcare solutions, and his collaborations highlight the importance of teamwork in driving innovation. Moniotte’s ongoing contributions continue to shape the future of drug development and exemplify the spirit of invention in the pharmaceutical industry.